MIOT
ADVM

Massachusetts Institute of Technology’s Adverum Biotechnologies ADVM Stock Holding History

Massachusetts Institute of Technology’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.45M Buy
+13,415
New +$1.66M 1.63% 4

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Massachusetts Institute of Technology's ADVM Position: Q4 2020 in Review

Massachusetts Institute of Technology opened a new position in Adverum Biotechnologies (ADVM) in Q4 2020: 13,415 shares worth $1.45M. The stake represents 1.63% of the portfolio and ranks #4 among its holdings.

155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Massachusetts Institute of Technology held 13,415 shares of Adverum Biotechnologies worth $1.45M as of Q4 2020.
  • Adverum Biotechnologies was a new Massachusetts Institute of Technology position in Q4 2020.
  • Adverum Biotechnologies made up 1.63% of Massachusetts Institute of Technology's portfolio in Q4 2020, its #4 holding.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Massachusetts Institute of Technology's 13F filing for Q4 2020, filed 5 Feb 2021.